skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Refine Results

Clear All








99+ Total results for product and free and sample content found

Citeline Engage: Supporting clinical trial pl...

5 Patient Engagement & Recruitment Trends, and How to Keep Up with Them

23 Aug 2022

Here's look at five top trends shaping the pharmaceutical industry, assessing their impact on patient engagement and recruitment.

Trialtrove: 医療用医薬品の臨床試験情報データベース

Expanded Curation of Immuno-Oncology Combination Trials in Trialtrove

01 Jul 2022

To highlight the growing importance of IO and especially IO combination trials within oncology clinical development, visual trends and key insights about the past 20+ years were compiled.


Trumps Drug Pricing Plan: The Headlines Are The Goal - But Also A Threat

By Michael McCaughan 16 Jun 2022

US Election Drug Pricing Reform

The latest flurry of Executive Order activity on drug pricing reinforces the message that the President wants to own the headlines for being tough on the drug industry as Election Day looms. Looking for substance beyond that goal is a fool’s errand – but the headlines could still have significant consequences no matter who wins in November.

Topic US Election 2020

Medtech Insight: 世界の医療機器・医療技術の最新情報

US Election 2020: Almost All House Members Backed By Industry PAC Dollars Retain Seats

By Sue Darcey 16 Jun 2022

US Election 2020 PAC dollars

Out of 31 US House incumbents supported by high amounts of medtech industry political action committee (PAC) dollars, only one – Chrissy Houlahan of Pennsylvania – lost in last week’s election.

Topic US Election 2020 Policy & Regulation Legislation


China-US Relationship Hinges On Changing Internal, External Forces

By Brian Yang 16 Jun 2022

US Election China Relations

Given the ongoing election challenges in the US, China has yet to officially congratulate Joe Biden as the next US president, although many world leaders are already hailing a reset in US foreign policy. Many are wondering if this and other moves indicate a quiet internal shift for China's high tech and life sciences sectors, just days after Beijing concluded a high-level plenary meeting outlining its priorities for the next five years.

Topic US Election 2020 China

Datamonitor Healthcare: 医療用医薬品の市場調査レポート

Global Oncology Opportunities & Trends 2025: Key Markets, Indications and Product

13 May 2022

Pharma Intelligence

Join Informa Pharma Intelligence for the “Global Oncology Opportunities” webinar! 

Sitetrove: 治験責任医師と治験施設情報のデータベース

New pip codes for Northern Ireland and Great Britain

11 Mar 2022

We are pleased to announce that from mid-February 2022, C+D Data will provide the UK supply chain with additional product listings and associated PIP-codes for Northern Ireland (NI) and Great Britain (GB.)  This solution will allow you to reach the entire UK market quickly and facilitate the ordering and distribution of medicines without disruption to you, and your wholesalers – while ensuring the data’s accuracy, visibility, and long-term management.